Aurinia Reports Third Quarter 2014 Financial Results
November 12, 2014 09:00 ET
|
Aurinia Pharmaceuticals
VICTORIA, British Columbia, Nov. 12, 2014 (GLOBE NEWSWIRE) -- Aurinia Pharmaceuticals Inc. (Nasdaq:AUPH) (TSX:AUP) has released its financial results for the third quarter ended September 30, 2014....
Aurinia Pharmaceuticals to Host Lupus Opinion Leader Meeting and Webcast on October 23 in New York City
October 21, 2014 08:00 ET
|
Aurinia Pharmaceuticals
VICTORIA, British Columbia, Oct. 21, 2014 (GLOBE NEWSWIRE) -- Aurinia Pharmaceuticals Inc. (Nasdaq:AUPH) (TSX:AUP) today announced that it will host a Lupus Key Opinion Leader breakfast on Thursday,...
Aurinia Pharmaceuticals to Begin Trading on the NASDAQ Global Market
September 02, 2014 08:00 ET
|
Aurinia Pharmaceuticals
VICTORIA, B.C., Sept. 2, 2014 (GLOBE NEWSWIRE) -- Aurinia Pharmaceuticals Inc. (the "Company") (Nasdaq:AUPH) (TSX:AUP) today announced that the Company has received approval by the NASDAQ Listing...
Aurinia Reports Second Quarter 2014 Financial Results
August 14, 2014 16:30 ET
|
Aurinia Pharmaceuticals
VICTORIA, British Columbia, Aug. 14, 2014 (GLOBE NEWSWIRE) -- Aurinia Pharmaceuticals Inc. (TSX:AUP) has released its financial results for the second quarter and six months ended June 30, 2014. All...
Aurinia Pharmaceuticals to Present at the Canaccord Genuity 34th Annual Growth Conference
August 12, 2014 08:00 ET
|
Aurinia Pharmaceuticals
VICTORIA, British Columbia, Aug. 12, 2014 (GLOBE NEWSWIRE) -- Aurinia Pharmaceuticals, Inc., (TSX:AUP) today announced that its Chief Operating Officer Michael R. Martin will present a corporate...
Aurinia Adds Financial Expertise to Its Board of Directors
July 29, 2014 08:00 ET
|
Aurinia Pharmaceuticals
VICTORIA, British Columbia, July 29, 2014 (GLOBE NEWSWIRE) -- Aurinia Pharmaceuticals Inc. ("Aurinia" or the "Company") (TSX:AUP) today announced that Mr. Charles Rowland Jr. has joined its Board of...
Aurinia Pharmaceuticals Initiates Phase 2b Clinical Trial of Voclosporin to Treat Lupus Nephritis
June 26, 2014 08:00 ET
|
Aurinia Pharmaceuticals
VICTORIA, British Columbia, June 26, 2014 (GLOBE NEWSWIRE) -- Aurinia Pharmaceuticals, Inc., (TSX-V:AUP) today announced enrollment of the first patient in its planned Phase 2b clinical trial to...
Aurinia to Present at the BIO International Convention
June 23, 2014 08:00 ET
|
Aurinia Pharmaceuticals
VICTORIA, British Columbia, June 23, 2014 (GLOBE NEWSWIRE) -- Aurinia Pharmaceuticals, Inc., (TSX:AUP) today announced that its Chief Operating Officer, Michael R. Martin, will present a corporate...
Aurinia to Present at the Bloom Burton & Co. Healthcare Investor Conference
June 18, 2014 08:00 ET
|
Aurinia Pharmaceuticals
VICTORIA, British Columbia, June 18, 2014 (GLOBE NEWSWIRE) -- Aurinia Pharmaceuticals, Inc., (TSX:AUP) today announced that its President and Chief Executive Officer, Stephen Zaruby, will present a...
Aurinia to Commence Trading on Toronto Stock Exchange
June 11, 2014 08:00 ET
|
Aurinia Pharmaceuticals
VICTORIA, British Columbia, June 11, 2014 (GLOBE NEWSWIRE) -- Aurinia Pharmaceuticals Inc. ("Aurinia" or the "Company") (TSX-V:AUP) today announced that its common shares will commence trading on the...